EUVIMEDEUVIMED entdecken
Crossref

Central Composite Design Assisted Spectrofluorimetric Determination of Solifenacin via Quenching of Acid Red 51: Application in Pharmaceutical Formulations and Plasma

Ali Alqahtani, Taha Alqahtani, Adil Alshehri, Ahmed A Almrasy iD

Luminescence · 2025

DOI: 10.1002/bio.70296 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Luminescence, 2025. Verfasst von Ali Alqahtani und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, College of Pharmacy, King Khalid University, Abha, Saudi Arabia. Hauptthemen laut MEDLINE: Solifenacin Succinate. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Deanship of Research and Graduate Studies at King Khalid University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study describes the development and validation of a novel photochemical sensing platform based on the fluorescence quenching mechanism between acid red 51 (AR51) and solifenacin succinate (SLF). Upon excitation at 530 nm, AR51 exhibits native fluorescence at 554 nm, which undergoes significant quenching in the presence of SLF through ion pair complex formation. The photophysical interaction was characterized by Stern–Volmer analysis, revealing a quenching constant of 1.44 × 10 5 mol/L −1 , indicative of a static quenching mechanism. Job's plot confirmed a 1:1 stoichiometric ratio between AR51 and SLF. A central composite design optimized the experimental conditions affecting the photochemical interaction, with buffer pH, buffer volume, and AR51 concentration identified as critical parameters. Under optimized conditions (acetate buffer pH 4.2, 1.1 mL buffer volume, 1.1 mL AR51 solution), the method demonstrated linearity in the concentration range of 0.2 to 44 μg/mL with detection and quantification limits of 0.0554 and 0.1678 μg/mL, respectively. The developed sensor was successfully applied for SLF determination in pharmaceutical formulations and human plasma samples with recovery rates of 99.77% and 99.01%, respectively, offering advantages over conventional methods by operating at longer wavelengths, thereby minimizing interference from endogenous fluorophores.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Solifenacin SuccinateSpectrometry, FluorescenceHumansHydrogen-Ion ConcentrationDrug CompoundingMolecular StructureLimit of DetectionFluorescence

Stichwörter der Autor:innen

acid red 51central composite designplasmasolifenacinspectrofluorimetry

Substanzen

Solifenacin Succinate

Autor:innen und Institutionen

  • Department of Pharmacology, College of Pharmacy, King Khalid University, Abha, Saudi Arabia.
  • Department of Medicine, College of Medicine, King Khalid University, Abha, Saudi Arabia.
  • Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt.

ORCID-Profile: Ahmed A Almrasy

Förderung

  • Deanship of Research and Graduate Studies at King Khalid University

Zitieren

APA

Alqahtani, A., Alqahtani, T., Alshehri, A., & Almrasy, A. A. (2025). Central Composite Design Assisted Spectrofluorimetric Determination of Solifenacin via Quenching of Acid Red 51: Application in Pharmaceutical Formulations and Plasma. Luminescence. https://doi.org/10.1002/bio.70296

Vancouver

Alqahtani A, Alqahtani T, Alshehri A, Almrasy AA. Central Composite Design Assisted Spectrofluorimetric Determination of Solifenacin via Quenching of Acid Red 51: Application in Pharmaceutical Formulations and Plasma. Luminescence. 2025. doi:10.1002/bio.70296

BibTeX
@article{Alqahtani2025,
  author = {Alqahtani, Ali and Alqahtani, Taha and Alshehri, Adil and Almrasy, Ahmed A},
  title = {Central Composite Design Assisted Spectrofluorimetric Determination of Solifenacin via Quenching of Acid Red 51: Application in Pharmaceutical Formulations and Plasma},
  journal = {Luminescence},
  year = {2025},
  doi = {10.1002/bio.70296}
}
Kostenlos starten →